Dr. Aliasgar Patanwala is a seasoned healthcare access strategist and pharmaceutical professional, currently serving as Lead – Market Access at Servier India, where he drives strategic initiatives to improve patient access to innovative therapies and diagnostics across the Indian healthcare ecosystem. In his role, he focuses on strengthening coordination between pharmaceutical solutions, healthcare providers, diagnostic partners, and public health stakeholders to ensure that clinical progress translates into real-world access for patients. A key part of his work involves developing collaborative models that address affordability, affordability gaps, and systemic barriers that impact timely diagnosis and equitable care.

Under his market access leadership, Servier has undertaken impactful programs such as the rollout of a patient-centric biomarker testing initiative for Acute Myeloid Leukemia (AML) and Cholangiocarcinoma in collaboration with MedGenome and Strand Life Sciences, aimed at expanding access to precision diagnostics across private and government health sectors in India. In commenting on the program, Dr. Patanwala emphasized that real access is built through collaborative systems—strengthening last-mile coordination between laboratories, clinicians, and patient pathways to ensure that advanced diagnostics are both affordable and practically available to doctors and patients alike.

Earlier engagements from his professional journey reflect a deep grounding in health economics, market access, health technology assessment (HTA) frameworks, and healthcare financing—including speaking engagements where he has shared insights on India’s evolving payer ecosystem, pooled financing mechanisms, and strategic approaches that bridge innovation with patient care.

Dr. Patanwala’s work exemplifies a blend of patient-centric market access strategy, policy engagement, and implementation alignment, enabling better integration of advanced therapies and diagnostics into India’s diverse health landscape while advocating for equitable healthcare solutions.